Table 3.
Metabolite concentrations (in institutional units) in the FWM, FGM, PGM and BG regions among the subjects by gender
| Voxel location | NAA | Cr | Cho | Glu |
|---|---|---|---|---|
| FWM | ||||
| Men (N=30) | 8.05±0.14 * | 4.82±0.11 ** | 2.16±0.05 | 5.21±0.17 *** |
| Women (N=20) | 7.92±0.19 a | 4.93±0.11 | 2.10±0.06 b | 5.71±0.23 c |
| FGM | ||||
| Men (N=30) | 7.85±0.12 | 5.83±0.15 | 1.99±0.06 | 7.16±0.18 |
| Women (n=19) | 7.49±0.16 | 5.85±0.21 | 2.02±0.08 | 7.54±0.25 |
| PGM | ||||
| Men (n=26) | 8.26±0.13 | 6.22±0.13 | 1.50±0.05 | 7.35±0.24 |
| Women (n=16) | 7.98±0.25 | 5.95±0.16 | 1.44±0.04 | 6.64±0.24 |
| BG | ||||
| Men (n=28) | 7.90±0.11 | 4.62±0.11 | 1.52±0.07 | 3.85±0.21 |
| Women (n=19) | 7.29±0.15 | 4.63±0.11 | 1.52±0.05 | 4.09±0.24 |
Values are reported as mean±S.E.
*
Effect of region is significant by analysis of variance (ANOVA), P<.0001.
**
Effect of region is significant by ANOVA, P=.0057.
***
Effect of region is significant by ANOVA, P<.0001.
a
Effect of region is significant by ANOVA, P=.024.
b
Effect of region is significant by ANOVA, P=.025.
c
Effect of region is significant by ANOVA, P=.033.